COVID-19.
UofL breakthrough technology shows promise fighting novel coronavirus
University of Louisville researchers have developed a technology that is believed to block the novel coronavirus SARS-CoV-2 from infecting human cells. The technology is based...
COVID-19.
Commonwealth of Kentucky launches initiative to test healthcare workers for immunity and establish top plasma donor pool
The Commonwealth of Kentucky, in collaboration with the University of Louisville Christina Lee Brown Envirome Institute and the Louisville Healthcare CEO Council, is launching...
Andrew Meas, a research participant at UofL with a complete spinal cord injury, with members of the resarch team, Claudia Angeli, Susan Harkema and Enrico Rejc,.
Individual with complete spinal cord injury regains voluntary motor function Extended activity-based training with epidural stimulation resulted in ability to stand and move without stimulation
Andrew Meas, a research participant at the University of Louisville with a complete spinal cord injury, who had lost motor function below the level...
Qualigen CEO Michael Poirier and UofL's Paula Bates
Potential UofL coronavirus breakthrough in development with California biomedical company
A promising University of Louisville technology believed to block the novel coronavirus SARS-CoV-2 from infecting human cells now has a commercial partner. The California biomedical...
A confocal microscope image shows the SA-4-1BBL (green color) bound to its receptor on an immune cell (red color) to initiate an immune activation cascade to fight cancer. Image courtesy University of Louisville.
UofL researchers discover immune stimulant molecule shown to prevent cancer
A research team at the University of Louisville has discovered that an immune checkpoint molecule they developed for cancer immunotherapy also protects against future...
A clinical trial for Aviptadil (RLF-100) is underway at UofL for severe COVID-19 patients. Image courtesy NeuroRx.
UofL conducting clinical trial on drug for severe COVID-19 respiratory effects
The University of Louisville is conducting a clinical trial on a new treatment for critically ill COVID-19 patients meant to lessen some of the...
Map 2: Prevalence of COVID-19 in Jefferson County in June 2020.
Phase II results of Co-Immunity Project show higher-than-expected rates of coronavirus exposure in Jefferson County
Results from the second phase of the University of Louisville’s groundbreaking project to track COVID-19 in Jefferson County show that 4 to 6 times...
Breonna Taylor Memorial Scholarship.
UofL nursing scholarship created to honor Breonna Taylor
To honor the memory of the EMT from Louisville, the UofL Health Board of Directors is creating a nursing scholarship in the name of...
Grawemeyer is lit green to honor COVID-19 victims in 2020.
A look back at a very unusual – and unprecedented – year at UofL
If we could describe 2020 in one word for posterity, it’d no doubt be “memorable.” Hopefully it will also be anomalous. This year was largely defined...
Campus in the middle of fall
UofL releases plan for the Fall 2020 semester
The University of Louisville has released several key actions and guidelines to ensure a safe return to campus for the Fall 2020 semester. UofL...